These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

259 related articles for article (PubMed ID: 22201591)

  • 1. Nanocarriers to solid tumors: considerations on tumor penetration and exposure of tumor cells to therapeutic agents.
    Bhagat M; Halligan S; Sofou S
    Curr Pharm Biotechnol; 2012 Jun; 13(7):1306-16. PubMed ID: 22201591
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Alteration of tumor microenvironment for improved delivery and intratumor distribution of nanocarriers.
    Ishida T; Kiwada H
    Biol Pharm Bull; 2013; 36(5):692-7. PubMed ID: 23649327
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Intratumoral drug delivery with nanoparticulate carriers.
    Holback H; Yeo Y
    Pharm Res; 2011 Aug; 28(8):1819-30. PubMed ID: 21213021
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The rise and rise of stealth nanocarriers for cancer therapy: passive versus active targeting.
    Huynh NT; Roger E; Lautram N; Benoît JP; Passirani C
    Nanomedicine (Lond); 2010 Nov; 5(9):1415-33. PubMed ID: 21128723
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Size shrinkable drug delivery nanosystems and priming the tumor microenvironment for deep intratumoral penetration of nanoparticles.
    Niu Y; Zhu J; Li Y; Shi H; Gong Y; Li R; Huo Q; Ma T; Liu Y
    J Control Release; 2018 May; 277():35-47. PubMed ID: 29545106
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The ligand nanoparticle conjugation approach for targeted cancer therapy.
    Karra N; Benita S
    Curr Drug Metab; 2012 Jan; 13(1):22-41. PubMed ID: 21892918
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Using Properties of Tumor Microenvironments for Controlling Local, On-Demand Delivery from Biopolymer-Based Nanocarriers.
    Alshememry AK; El-Tokhy SS; Unsworth LD
    Curr Pharm Des; 2017; 23(35):5358-5391. PubMed ID: 28530543
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Recent advances in drug delivery systems for enhancing drug penetration into tumors.
    He B; Sui X; Yu B; Wang S; Shen Y; Cong H
    Drug Deliv; 2020 Dec; 27(1):1474-1490. PubMed ID: 33100061
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Nanocarriers for the simultaneous co-delivery of therapeutic genes and anticancer drugs.
    Choudhury NN; He H
    Curr Pharm Biotechnol; 2012 Jun; 13(7):1317-31. PubMed ID: 22201588
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Liposomes a vesicular nanocarrier: potential advancements in cancer chemotherapy.
    Kumar P; Gulbake A; Jain SK
    Crit Rev Ther Drug Carrier Syst; 2012; 29(5):355-419. PubMed ID: 22876808
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Novel Nanoparticles for Tumor Targeting Drug Delivery.
    Gao H
    Curr Drug Metab; 2018; 19(9):722. PubMed ID: 30187836
    [No Abstract]   [Full Text] [Related]  

  • 12. Tumor vascular-targeted co-delivery of anti-angiogenesis and chemotherapeutic agents by mesoporous silica nanoparticle-based drug delivery system for synergetic therapy of tumor.
    Li X; Wu M; Pan L; Shi J
    Int J Nanomedicine; 2016; 11():93-105. PubMed ID: 26766908
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prodrug-based nanoparticulate drug delivery strategies for cancer therapy.
    Luo C; Sun J; Sun B; He Z
    Trends Pharmacol Sci; 2014 Nov; 35(11):556-66. PubMed ID: 25441774
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Active targeting strategies for anticancer drug nanocarriers.
    Basile L; Pignatello R; Passirani C
    Curr Drug Deliv; 2012 May; 9(3):255-68. PubMed ID: 22452402
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Recent Advances in Nanoparticle-Based Cancer Drug and Gene Delivery.
    Amreddy N; Babu A; Muralidharan R; Panneerselvam J; Srivastava A; Ahmed R; Mehta M; Munshi A; Ramesh R
    Adv Cancer Res; 2018; 137():115-170. PubMed ID: 29405974
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Nanocarriers for cancer-targeted drug delivery.
    Kumari P; Ghosh B; Biswas S
    J Drug Target; 2016; 24(3):179-91. PubMed ID: 26061298
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Smart Drug Delivery Systems in Cancer Therapy.
    Unsoy G; Gunduz U
    Curr Drug Targets; 2018 Feb; 19(3):202-212. PubMed ID: 27033191
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Advances in Functionalized Mesoporous Silica Nanoparticles for Tumor Targeted Drug Delivery and Theranostics.
    Zhang W; Liu M; Liu A; Zhai G
    Curr Pharm Des; 2017; 23(23):3367-3382. PubMed ID: 27784244
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Nanocarrier-Based Therapeutics and Theranostics Drug Delivery Systems for Next Generation of Liver Cancer Nanodrug Modalities.
    Ruman U; Fakurazi S; Masarudin MJ; Hussein MZ
    Int J Nanomedicine; 2020; 15():1437-1456. PubMed ID: 32184597
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Co-delivery strategies based on multifunctional nanocarriers for cancer therapy.
    Chen H; Zhao Y; Wang H; Nie G; Nan K
    Curr Drug Metab; 2012 Oct; 13(8):1087-96. PubMed ID: 22380013
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.